Table 3.
Magnitude of Statistically Significant Association Found in the Adjusted Analysis
| Risk Factors to Develop ACS in Patients With COVID-19 Compared With Control A (COVID-19 Patients Not Developing ACS) | OR (95% CI) |
|---|---|
| Compared with baseline characteristics | |
| Coronary artery disease | 5.86 (3.14–10.95) |
| Age ≥60 years | 2.34 (1.19–4.62) |
| Hypertension | 2.15 (1.16–3.98) |
| Compared with clinical characteristics of the episode | |
| Chest pain | 16.22 (8.49–31.02) |
| Raised troponin (>99th percentile) | 4.93 (2.32–10.46) |
| Hypoxemia (pulse oximetry <96%) | 2.33 (1.19–4.56) |
| Symptoms lasting >3 days | 0.35 (0.19–0.64) |
| Characteristics of ACS in patients with COVID-19 compared with control B (ACS in non–COVID-19 patients) | |
| Compared with baseline characteristics | |
| None achieved statistical significance in the adjusted model) | — |
| Compared with clinical characteristics of the episode | |
| Fever (>37.3°C) | 13.70 (3.87–48.53) |
| Diarrhea | 6.38 (1.45–28.08) |
| Cough | 6.09 (2.25–16.49) |
| Dyspnea | 2.53 (1.31–4.87) |
| Lymphopenia (<1000 µL/mL) | 2.40 (1.20–4.79) |
The number of patients presenting the baseline and current episode conditions in each group can be found in Table 1.
ACS = acute coronary syndrome; CI = confidence interval; OR = odds ratio.